Human neural stem cells: Phase I/II started

StemCells began an open-label, dose-escalation, U.S. Phase I/II trial to evaluate intraocular HuCNS-SC in about 16 patients with dry AMD. The product is also in Phase I/II testing to treat chronic spi...